Inactive Instrument

News Ambrx Biopharma Inc. Nasdaq

Equities

AMAM

US02290A1025

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

Ambrx Biopharma Inc. Announces Resignation of Andrew Aromando as Chief Operating Officer	Mar. 12	CI
Johnson & Johnson Completes Ambrx Acquisition	Mar. 07	MT
J&J: completes $2 billion acquisition of Ambrx Biopharma	Mar. 07	CF
Ambrx Biopharma Inc.(NasdaqGS:AMAM) dropped from NASDAQ Composite Index	Mar. 06	CI
Johnson & Johnson completed the acquisition of Ambrx Biopharma Inc. from a group of shareholders.	Mar. 06	CI
Ambrx Biopharma Inc.(NasdaqGS:AMAM) dropped from S&P Global BMI Index	Mar. 06	CI
Ambrx Biopharma Shareholders Approve Johnson & Johnson Acquisition Deal	Mar. 06	MT
Ambrx Shareholders Approve Acquisition by Johnson & Johnson	Mar. 06	AQ
Ambrx Biopharma Inc.(NasdaqGS:AMAM) dropped from NASDAQ Biotechnology Index	Mar. 05	CI
J&J's Acquisition of Ambrx Biopharma Completes Hart-Scott-Rodino Waiting Period	Feb. 22	MT
Sanofi to Buy Assets From Inhibrx in Deal Valued at Up to $2.2 Billion -- Update	Jan. 23	DJ
North American Morning Briefing : Central Bankers -2-	Jan. 17	DJ
North American Morning Briefing : Focus Fixed on -2-	Jan. 11	DJ
JMP Securities Downgrades Ambrx Biopharma to Market Perform From Market Outperform	Jan. 10	MT
Global markets live: Boeing, GSK, Hays, Shell, Eli Lilly...	Jan. 09
B. Riley Downgrades Ambrx Biopharma to Neutral From Buy on Heels of Announced Sale to Johnson & Johnson, Adjusts PT to $28 From $26	Jan. 09	MT
Health Care Up as Merger Wave Continues -- Health Care Roundup	Jan. 08	DJ
Sector Update: Health Care Stocks Rise Late Afternoon	Jan. 08	MT
News Highlights : Top Company News of the Day - Monday at 3 PM ET	Jan. 08	DJ
Trending : Johnson & Johnson and Merck & Co. Announce Acquisitions	Jan. 08	DJ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Ambrx Biopharma Inc. Nasdaq

Equities

AMAM

US02290A1025

Summary

Filters